The SCALE Kids trial, summarized here by NEJM Editorial Fellow Harleen Marwah, MD, assessed the efficacy and safety of liraglutide, as compared with placebo, as an adjunct treatment to lifestyle interventions, for the treatment of obesity in children 6 to 12 years of age. Full trial results: https://nej.md/3MBP1uc | The New England Journal of Medicine
1:56
The SCALE Kids trial, summarized here by NEJM Editorial Fellow Harleen Marwah, MD, assessed the efficacy and safety of liraglutide, as compared with placebo, as an adjunct treatment to lifestyle interventions, for the treatment of obesity in children 6 to 12 years of age. Full trial results: https://nej.md/3MBP1uc | The New England Journal of Medicine
已浏览 4364 次2025年3月15日
FacebookThe New England Journal of Medicine
展开
静态缩略图占位符